Skip to main content
. Author manuscript; available in PMC: 2020 Jun 29.
Published in final edited form as: J Neuroimaging. 2020 Feb 10;30(3):297–302. doi: 10.1111/jon.12694

Table 1.

Patient Characteristics by Device Type

Variable ECMO HVAD HMII TAH Impella IABP P Value
Number of patients with TCD studies 22 16 5 12 7 7
Mean age (SD) (years) 57 (11) 55 (12) 62 (14) 54 (11) 58 (12) 60 (14) .8
Female 5 (23) 2 (13) 0 (0) 1 (8.3) 1 (14) 1 (14) .3
Ethnicity
African American 1 (5) 2 (13) 1 (20) 2 (17) 0 (0) 0 (0) .7
Asian 5 (23) 1 (6) 0 (0) 3 (25) 1 (14) 3 (43) .2
Caucasian 12 (55) 7 (44) 4 (80) 5 (42) 5 (71) 4 (57) .4
Hispanic 2 (9) 2 (31) 0 (0) 2 (17) 1 (14) 0 (0) .5
Median preimplant NYHA [IQR] (years) 4 [4,4] 4 [3,4] 3.5 [3,4] 4 [3,4] 4 [4,4] 3.5 [3,4] .3

Note: Numbers are reported as number of patients (percent of group) unless otherwise specified.

BMI = body mass index; ECMO = extracorporeal membrane oxygenation; HMII = Heartmate II; HVAD = HeartWare ventricular assist device; IABP = intra-arterial balloon pump; IQR = interquartile range; NYHA = New York Heart Association; SD = standard deviation; TAH = total artificial heart; TCD = transcranial Doppler.